MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (rating agencies)
- CARE RATING
CARE RATING Share Price (CARE)
Here is the latest stock price and chart of Credit Analysis. For more details, see the Credit Analysis company fact sheet and quarterly results.
2020 Special Report : 7 Stocks to Ride the Coming Rebirth of India Rally. Full Details Here...
| Live BSE Quotes | Feb 14, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)526.40 | Open (Rs) 548.00 | High (Rs) 558.75 | Low (Rs) 523.70 |
| % Change-3.03 | Volume 34,417 | Value (Rs) 18,656,280 | 52-Week H/L 1,019.00 / 444.50 |
| Live NSE Quotes | Feb 14, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)527.30 | Open (Rs) 542.70 | High (Rs) 558.60 | Low (Rs) 523.85 |
| % Change-2.56 | Volume 490,393 | Value (Rs) 265,277,984 | 52-Week H/L 1,018.00 / 443.70 |
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 36.04 | P/E Ratio (x) 14.61 | Market Cap (Rs m) 15,260.34 | P/BV (x) 2.77 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
Peer Group:
Quote & GraphS&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
CARE RATING Share Price Today:
CARE RATING last traded price was down 3.0% to Rs 526.4 on the BSE. On the NSE, CARE RATING last traded price was down 2.6% to Rs 527.3. The total volume of shares traded was 0.5 m.
Overall, the benchmark S&P BSE SENSEX was at 41,257.7 (down 0.5%).
Over the last 30 days, the CARE RATING share price is down 10.8%. And over the last one year, CARE RATING share price is down 44.6%.
Today's Market
Sensex Ends 202 Points Lower; Power and Metal Stocks Witness Selling(Closing)
Indian share markets witnessed most of the selling pressure during closing hours today and ended lower.
Related Views On News
CARE RATING Announces Quarterly Results (3QFY20); Net Profit Down 42.8% (Quarterly Result Update)
Feb 10, 2020 | Updated on Feb 10, 2020For the quarter ended December 2019, CARE RATING has posted a net profit of Rs 176 m (down 42.8% YoY). Sales on the other hand came in at Rs 561 m (down 23.0% YoY). Read on for a complete analysis of CARE RATING's quarterly results.
CARE RATING 2018-19 Annual Report Analysis (Annual Result Update)
Oct 7, 2019 | Updated on Oct 7, 2019Here's an analysis of the annual report of CARE RATING for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CARE RATING. Also includes updates on the valuation of CARE RATING.
CARE RATING Announces Quarterly Results (1QFY20); Net Profit Down 47.2% (Quarterly Result Update)
Aug 5, 2019 | Updated on Aug 5, 2019For the quarter ended June 2019, CARE RATING has posted a net profit of Rs 135 m (down 47.2% YoY). Sales on the other hand came in at Rs 499 m (down 13.1% YoY). Read on for a complete analysis of CARE RATING's quarterly results.
More Views on NewsMost Popular
Buy this 'Crorepati Stock' and You Could End Up Stinking Rich (Profit Hunter)
Feb 5, 2020I'm talking about an individual small cap stock that could go up so many times that they make their investors stinking rich in the process. You definitely want to know more...
This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years) (Profit Hunter)
Feb 11, 2020A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.
How to Prevent the Market from Taking Your Money (Fast Profits Daily)
Feb 3, 2020Watch out! These are times when the market will try to fool you.
Will Your Trade Go Up or Down Today? (Fast Profits Daily)
Feb 5, 2020How you can find out which way your trade is likely to move on any given trading day.
A Quantum Budget? (The Honest Truth)
Feb 3, 2020Ajit Dayal on the Union Budget 2020-21.
MoreOUR TOP 5 IDEAS
- Free Guide on How to Profit from Sensex 100,000.
- A Simple Test to Find out If a Stock Has 100x Potential
- A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Revealed: Top 7 Stocks to Consider Buying Right Now...
TRACK CARE RATING
- Track your investment in CARE RATING with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON CARE RATING
CARE RATING - CRISIL COMPARISON
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.